melanocortinbased peptide pt141. PT-141 (Bremelanotide) PT-141 (Bremelanotide) Peptide Therapy in
Description
A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita
During pregnancy, women carrying fetuses with CPT II deficiency may be at increased risk to develop serious medical problems
doi:10.1073/pnas.172378699
[Research shows] we are less likely to survive skin care due to late diagnosis
